MDWD - MediWound Ltd. (MDWD) CEO Sharon Malka on Q1 2022 Results - Earnings Call Transcript

MediWound Ltd. (MDWD) Q1 2022 Earnings Conference Call May 17, 2022 08:30 A.M. ET Company Participants Monique Kosse - IR Sharon Malka - CEO Boaz Gur-Lavie - Chief Financial Officer Ofer Gonen - Board Member Lior Rosenberg - Chief Medical Officer Cyaandi R. Dove - Investigator, Advanced Wound & Ankle Center, Las Vegas Conference Call Participants Unidentified Analyst - Cowen and Company Kevin DeGeeter - Oppenheimer Arthur He - H.C. Wainwright Presentation Operator Good day and welcome to the MediWound First Quarter 2022 Financial Results and Presentation of the EscharEx Phase 2 Clinical Trial Results Conference Call. At this time all participants are in a listen-only mode. Following management’s prepared remarks we will hold a Q&A session. [Operator Instructions]. At this time I would like to turn the conference over to Monique Kosse of LifeSci Advisors. Please go ahead. Monique Kosse Thank you, operator and welcome everyone. Earlier today, MediWound

For further details see:

MediWound Ltd. (MDWD) CEO Sharon Malka on Q1 2022 Results - Earnings Call Transcript